Asthma Monitoring Device Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device (Spirometer, Smart Inhalers, Peak Flow Meter), By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 302.98 MIllion
CAGR (2026-2031)	6.26%
Fastest Growing Segment	Smart Inhalers
Largest Market	North America
Market Size (2031)	USD 436.15 MIllion

Market Overview

The Global Asthma Monitoring Device Market will grow from USD 302.98 MIllion in 2025 to USD 436.15 MIllion by 2031 at a 6.26% CAGR. Asthma monitoring devices are specialized medical tools such as peak flow meters and smart inhalers designed to measure lung function and track respiratory symptoms. The primary drivers supporting market growth include the increasing global prevalence of chronic respiratory conditions and the expanding adoption of remote patient management technologies. These factors create a sustained demand for effective disease control solutions and differ significantly from passing market trends.

One major challenge hindering broader market expansion is the substantial cost associated with advanced digital monitoring systems and limited reimbursement policies in emerging economies. According to the Global Initiative for Asthma, in 2024, this chronic disease affected over 260 million people globally. This statistic underscores the urgent need for affordable monitoring solutions as economic barriers currently prevent a large segment of this patient population from accessing modern device technology.

Key Market Drivers

The rising global prevalence of asthma and chronic respiratory diseases serves as the primary engine driving the asthma monitoring device market. As patient populations expand, the necessity for effective management tools intensifies, particularly in regions facing environmental challenges. According to the American Lung Association, in 2024, approximately 131.2 million people in the United States lived in areas with unhealthy pollution levels, creating a critical need for rigorous symptom tracking. This exposure drives demand for diagnostic aids to mitigate health risks and manage chronic conditions effectively. According to the Asthma and Allergy Foundation of America, September 2024, in the 'Asthma Capitals 2024 Report', nearly 28 million Americans currently live with asthma, highlighting the massive scale of the market requiring continuous intervention and home-based monitoring solutions.

Advancements in smart inhaler and digital health technologies are simultaneously transforming the sector by enabling proactive, data-driven care. Modern devices now integrate with cloud platforms to track medication adherence in real-time, significantly improving patient self-management. This technological integration is fueling substantial industrial growth as providers prioritize connected care ecosystems. According to AstraZeneca, February 2025, in the 'Annual Report and Form 20-F Information 2024', revenue for the Respiratory & Immunology division increased by 23%, reflecting the rapid uptake of advanced respiratory therapies and associated digital systems. These innovations reduce hospital readmissions and enhance clinical decision-making, establishing digital connectivity as a permanent and essential market component.

Download Free Sample Report

Key Market Challenges

The substantial cost associated with advanced digital monitoring systems and limited reimbursement policies stands as a critical barrier to the growth of the Global Asthma Monitoring Device Market. While these technologies offer superior capability in tracking respiratory function, their high price point renders them inaccessible to a vast segment of the patient population, particularly in emerging economies where out-of-pocket healthcare expenses are common. This economic divide restricts the adoption of smart inhalers and digital peak flow meters to affluent demographics, preventing the market from reaching its full volume potential. When patients must choose between purchasing essential medication and acquiring a supplementary monitoring tool, financial constraints invariably dictate that immediate treatment takes precedence over tracking.

The severity of this economic pressure is illustrated by the immense financial burden the condition already places on healthcare infrastructures and individuals. According to the Asthma and Allergy Foundation of America, in 2024, the annual economic cost of asthma in the United States was estimated at more than $82 billion. This staggering figure highlights the financial strain on the healthcare ecosystem, making it difficult for payers and providers to justify or absorb the additional costs of expensive monitoring devices without comprehensive insurance coverage. Consequently, until these economic hurdles are addressed, the market is likely to experience stunted expansion in cost-sensitive regions.

Key Market Trends

The Integration of Artificial Intelligence for Predictive Exacerbation Analytics is fundamentally shifting the market from reactive symptom tracking to proactive disease forecasting. Unlike traditional monitoring which records historical data, advanced algorithms now analyze respiratory patterns to anticipate attacks before they manifest physically. This capability allows for preemptive clinical intervention, significantly reducing the risk of hospitalization for vulnerable patient groups. According to MPO Magazine, December 2024, in the 'Albus Health Device Detects Early Warning Signs of Child Asthma Attacks' report, a new non-contact monitoring device utilizes AI to successfully identify respiratory changes and predict asthma exacerbations up to five days before they occur. This shift towards predictive intelligence transforms the device from a simple measurement tool into a critical early-warning system, altering the standard of care for chronic respiratory management.

Simultaneously, the Integration of Real-Time Patient Data into Electronic Health Records is addressing the market's accessibility challenges by leveraging passive digital markers within existing medical infrastructures. This trend focuses on utilizing routinely collected health data to stratify risk without requiring expensive, standalone hardware for every patient, thereby bypassing the economic barriers associated with high-end monitoring devices. By embedding analysis directly into clinical workflows, providers can identify high-risk individuals using population-level data. According to Docwire News, July 2025, in the 'New AI-Driven Tool Flags Children at Risk for Asthma' article, a study reviewing medical records from nearly 70,000 children demonstrated that a passive digital marker could predict asthma diagnosis and risk with greater accuracy than traditional scoring methods. This integration effectively democratizes advanced monitoring, enabling scalable, data-driven disease management across broader demographics.

Segmental Insights

Smart inhalers represent the fastest-growing segment within the Global Asthma Monitoring Device Market, driven by the critical need to improve medication adherence and facilitate remote patient management. This expansion is significantly supported by regulatory advancements, such as approvals from the U.S. Food and Drug Administration for digital sensors that integrate with standard inhalers. These devices enable the real-time tracking of dosage and inhalation techniques, providing healthcare professionals with actionable data to optimize treatment plans. Consequently, the increasing adoption of connected health technologies fosters the rapid development of this segment.

Regional Insights

North America maintains a dominant position in the Global Asthma Monitoring Device Market, primarily driven by advanced healthcare infrastructure and the widespread adoption of digital respiratory management technologies. The region's market strength is bolstered by data and initiatives from the Centers for Disease Control and Prevention, which underscore the critical need for effective asthma control strategies. Additionally, the U.S. Food and Drug Administration supports the sector through streamlined regulatory approvals for innovative products, such as smart inhalers and remote monitoring systems. These factors, combined with favorable reimbursement frameworks, secure North America’s status as the leading hub for market expansion.

Recent Developments

• In June 2025, Adherium Limited released a new iteration of its Hailie Smartinhaler platform featuring compatibility with AstraZeneca’s AIRSUPRA and Breztri Aerosphere inhalers. This product launch expanded the company's coverage of triple therapy inhalers in the United States market, offering a comprehensive digital solution for patients with moderate to severe asthma and COPD. The enhanced device incorporated sensors that attach to the inhalers to monitor medication usage and technique, transmitting data to a mobile app and provider portal. This development was part of the company's strategy to broaden its remote patient monitoring capabilities and support value-based care initiatives.
• In June 2024, Aseptika introduced the PUFFClicker3, a new universal smart inhaler dose tracker compatible with both pressurized metered-dose inhalers and dry powder inhalers. This device was developed to improve medication adherence among patients with respiratory conditions by tracking when and how inhalers are used. The launch featured a design that supports a wide range of inhalers and included a touch screen with animated instructions to guide patients on correct usage techniques. The product aimed to address the significant challenge of inhaler adherence in asthma management by providing patients and caregivers with actionable data on medication compliance.
• In March 2024, ChestPal launched its ChestPal Pro digital stethoscope in the United States healthcare market following its FDA clearance. This innovative monitoring device was designed to support the early detection and management of respiratory conditions, including asthma, by capturing and analyzing lung sounds such as wheezing and crackles. The device integrated a high-quality digital stethoscope with advanced software that utilized automated algorithms to classify lung sounds, thereby aiding clinicians in making accurate diagnoses. The launch targeted healthcare professionals seeking to improve patient outcomes through enhanced respiratory assessment tools that provide objective data during examinations.
• In January 2024, NuvoAir Medical announced that its Air Next Spirometer received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for in-home use. This regulatory milestone allowed the company to offer its digital spirometry device as a fully cleared solution for remote patient monitoring. The clearance enabled the device to be used for conducting full spirometry tests at home, providing critical clinical data to healthcare providers for managing conditions such as asthma and chronic obstructive pulmonary disease (COPD). This development aimed to enhance the capability of clinical teams to monitor lung function continuously and intervene early when health deteriorates.

Key Market Players

• COSMED srl.
• Teleflex Incorporated.
• SCHILLER.
• Hill-Rom, Inc.
• Koninklijke Philips N.V.
• ICU Medical, Inc.
• SDI Diagnostics
• AstraZeneca plc.
• Merck & Co., Inc

By Device	By End-User	By Region
Spirometer Smart Inhalers Peak Flow Meter	Hospitals & Clinics Homecare Diagnostic Laboratories	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Asthma Monitoring Device Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Asthma Monitoring Device Market, By Device:

• Spirometer
• Smart Inhalers
• Peak Flow Meter

• Asthma Monitoring Device Market, By End-User:

• Hospitals & Clinics
• Homecare
• Diagnostic Laboratories

• Asthma Monitoring Device Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE